Current controversies in the support of sepsis

Current Opinion in Critical Care

Volumn 20, Issue 6, 2014, Pages 681-684

  Chawla, Shalinee ^a   DeMuro, Jonas P ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Controversy; Infection; Sepsis; Severe sepsis; Surviving Sepsis Campaign

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE FACTOR; ANTIINFECTIVE AGENT; VASOCONSTRICTOR AGENT;

ANTIBIOTIC THERAPY; CLINICAL PROTOCOL; DISEASE SEVERITY; FLUID RESUSCITATION; HUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PUBLICATION; REVIEW; SEPSIS; SEPTIC SHOCK; EVIDENCE BASED MEDICINE; FLUID THERAPY; HOSPITALIZATION; TOTAL QUALITY MANAGEMENT;

ANTI-BACTERIAL AGENTS; EVIDENCE-BASED MEDICINE; FLUID THERAPY; GUIDELINES AS TOPIC; HOSPITALIZATION; HUMANS; QUALITY IMPROVEMENT; SEPSIS; VASOCONSTRICTOR AGENTS;

EID: 84927702691     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000154     Document Type: Review

References (23)

1. Elixhauser A, Friedman B, Stranges E. Agency for Healthcare Research and Quality, Rockville, MD. Septicemia in US Hospitals 2009. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf.
2. McCloskey RV, Straube RC, Sanders C, et al. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994; 121:1-5.
3. Zeni F, Freeman B. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25:1095-1100.
4. Sasse KC, Nauenberg E, Long A., et al. Long-term survival after intensive care unit admission with sepsis. Crit Care Med 1995; 23:1040-1047.
5. Angus DC, Linde-Zwirble WT, Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29:1303-1310.
6. Dellinger RP, Levy MM, Rhodes A, et al., Surviving Sepsis Campaign Guide-lines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637.
7. Rivers E, Nguyen B, Havstad S., et al., Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
8. Marik PE. Early management of severe sepsis: concepts and controversies. Chest 2014; 145:1401-1418.
9. Goldenberg NM, Steinberg BE, Slutsky A.S., Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011; 3:88s25.
10. Boyd JH, Forbes J, Nakada T., et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39:259-265.
11. Lobo DN, Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent 'prerenal' acute kidney injury?: con. Kidney Int 2014. 10.1038/ki.2014.105. [Epub ahead of print]
12. Scrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351:159-169.
13. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178.
14. Barbier C, Loubieres Y, Schmit C., et al. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients. Intensive Care Med 2004; 30:1740-1746.
15. Kumar A, Roberts D, Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
16. Ferrer R, Martin-Loeches I, Phillips G., et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42:1749-1755
17. Bochud P, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32 (SUPPL. 11):S495-S512.
18. Kumar A, Safdar N, Kethireddy S., Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 2010; 38:1651-1664.
19. Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes? Crit Care Med 2001; 5:294-298.
20. Asfar P, Meziani F, Hamel J-F, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370:1583-1593.
21. Vasu TS, Cavallazzi R, Hirani A., et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med 2012; 27:172-178.
22. Russell JA, Walley KR, Singer J, et al., VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887.
23. The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370:1683-1693.